MariMed Inc (MRMD): A trade war has nothing to do with they...

Reply Private New

Replies (1) Next 10 Prev Next

Send PM Follow Ignore

Followers	5
Posts	851
Boards Moderated	0
Alias Born	12/27/2017

SmokeABull

Re: hamvestor post# 442

Saturday, 06/16/2018 12:39:41 PM

Saturday, June 16, 2018 12:39:41 PM

A trade war has nothing to do with they way MRMD is trading. Trump has nothing to do with it either. It’s all about expansion and their need for cash.

Keep Last Read

Replies (1) Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

Detailed Quote

Recent MRMD News

Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/11/2024 09:30:47 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/11/2024 09:05:01 PM
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/07/2024 09:02:55 PM
Form 8-K - Current report • Edgar (US Regulatory) • 03/06/2024 10:06:10 PM
Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2023 10:03:37 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/09/2023 09:11:11 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/09/2023 09:07:54 PM
Form 8-K - Current report • Edgar (US Regulatory) • 11/08/2023 10:06:50 PM
Form 8-K - Current report • Edgar (US Regulatory) • 11/03/2023 11:35:02 AM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/30/2023 09:24:42 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/30/2023 09:17:46 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/06/2023 10:29:20 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/04/2023 06:45:17 PM
Form 8-K - Current report • Edgar (US Regulatory) • 08/02/2023 09:13:09 PM

More MRMD News

InvestorsHub NewsWire

NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM

ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM

Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM

Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM

Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM

Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM

Start posting your company's news

Only $200 per official company press release!

Volume
Day Range:
Bid Price
Ask Price
Last Trade Time:

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover